Collaboratively compiled and edited by Maureen McKelvey, Annika Rickne and Jens Laage-Hellman, a trio of economic experts, The Economic Dynamics of Modern Biotechnology is a seminal and invaluable resource presenting insight into the economic influence of modern biotechnology. Drawing upon examples from Europe to illustrate global trends, The Economic Dynamics of Modern Biotechnology applies theory to unravel the modern issues of exactly how new facets of knowledge interact with market processes and the formation of industries. Raising important theoretical and practical questions, chapters adddress such topics as risk management and the commercialization of human genetic testing, the impact of emerging bioinformatics, how to conceptualize and measure modern biotechnology, and much more. The Economic Dynamics of Modern Biotechnology is a welcome and recommended addition to modern economics shelves for students, teachers, and professionals alike, shedding light on a newly emerging dimension of the interplay between economic and life science forces.
Author(s): Maureen D. McKelvey, Annika Rickne, Jens Laage-Hellman
Edition: illustrated edition
Publisher: Edward Elgar
Year: 2004
Language: English
Pages: 430
City: Cheltenham, UK; Northampton, MA
Contents......Page 5
Contributors......Page 7
Preface......Page 9
PART I Introduction......Page 13
1. Introduction......Page 15
2. Conceptualizing and measuring modern biotechnology......Page 32
PART II Setting the scene......Page 53
3. Stylized facts about innovation processes in modern biotechnology......Page 55
4. The post-genome era: rupture in the organization of the life science industry ?......Page 88
5. An overview of biotechnology innovation in Europe: firms, demand, government policy and research......Page 111
PART III Challenging the existing......Page 145
6. Risk management and the commercialization of human genetic testing in the UK......Page 147
7. Networks and technology systems in science-driven fields: the case of European food biotechnology......Page 179
8. Future imperfect: the response of the insurance industry to the emergence of predictive genetic testing......Page 219
9. Emergent bioinformatics and newly distributed innovation processes......Page 247
PART IV Forming the new......Page 275
10. The dynamics of regional specialization in modern biotechnology: comparing two regions in Sweden and two regions in Australia, 1977–2001......Page 277
11. On the spatial dimension of firm formation......Page 307
12. Examining the marketplace for ideas: how local are Europe’s biotechnology clusters?......Page 338
13. Creation and growth of high-tech SMEs: the role of the local environment......Page 368
PART V Conclusions......Page 405
14. Reflections and ways forward......Page 407
Index......Page 419
